Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) — Form 144: Proposed sale of shares
About this filing
Alnylam Pharmaceuticals, Inc. (ALNY) filed Form 144 (proposed sale of shares) with the SEC on Oct 2, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- SUPRAN BRYAN
- Relationship
- Officer
- Shares to sell
- 1,758
- Market value
- $398,862.25
- Approximate sale date
- Oct 2, 2026
- Broker
- Fidelity Brokerage Services LLC
- Acquired
- Oct 1, 2026 · Restricted Stock Vesting
Remarks
- Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
More ALNY filings
- SC 13G
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 4
Filed Oct 6, 2026
- 4
Filed Sep 22, 2026
- 10-Q
Filed Jul 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.